What is the appropriate intramuscular injection site for the tetanus toxoid vaccine in adults and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tetanus Toxoid Injection Site

For tetanus toxoid vaccines, use the anterolateral thigh in children ≤2 years of age and the deltoid muscle in children ≥3 years and all adults.

Age-Specific Injection Sites

Infants and Young Children (≤2 years)

  • The anterolateral aspect of the thigh is the preferred site for all tetanus-containing vaccines (DTaP, DT) in infants and children through age 2 years 1, 2, 3.
  • The standard dose is 0.5 mL administered intramuscularly 1, 2.
  • This site minimizes the risk of nerve injury and provides adequate muscle mass for vaccine absorption 3.

Children ≥3 Years

  • The deltoid muscle becomes the preferred injection site starting at age 3 years 1, 2, 3.
  • Continue using 0.5 mL intramuscular administration 1, 2.
  • Research demonstrates that deltoid injection at 18 months and older results in significantly less severe pain (8.1% vs 30.5%) and decreased limping compared to thigh injection 4.

Adolescents and Adults (≥7 years)

  • The deltoid muscle is the preferred and recommended site for Tdap and Td vaccines 2, 3, 5.
  • Administer 0.5 mL intramuscularly 2, 3, 5.
  • The FDA label explicitly states the deltoid is preferred and warns against gluteal injection or areas with major nerve trunks 5.

Technical Administration Guidelines

Needle Selection and Technique

  • Use 22-25 gauge needles for all age groups 6.
  • For adults: 1 to 1½ inches in length 6.
  • For children: 7/8 to 1¼ inches based on muscle size 6.
  • Administer at a 90-degree angle into the muscle 6.

Critical Safety Considerations

  • Never inject into the gluteal area due to risk of sciatic nerve injury 5.
  • Do not administer intravenously or subcutaneously 5.
  • Intramuscular administration produces significantly fewer local reactions than subcutaneous injection, with less redness (p<0.001), swelling (p<0.001), and pain (p<0.05) 7.

Common Pitfalls to Avoid

Site Selection Errors

  • Historical data shows that 13-16% of DPT injections were administered at incorrect sites (deltoid, gluteal, or ventrogluteal) in infants who should have received thigh injections 8.
  • Avoid the temptation to use the deltoid in children <3 years despite smaller muscle mass making the thigh more appropriate 1, 3.

Multiple Vaccine Administration

  • When administering multiple vaccines simultaneously, use separate syringes at different anatomic sites 3.
  • Some experts recommend no more than two injections per muscle, separated by at least one inch 3.

Post-Vaccination Monitoring

  • Observe patients for 15 minutes after vaccination, especially adolescents and young adults, due to syncope risk 1, 3, 6.
  • Have epinephrine 1:1,000 immediately available for potential anaphylactic reactions 5.

Evidence-Based Rationale for Site Selection

The preference for thigh injection in younger children and deltoid in older children/adults is supported by both safety and reactogenicity data. For DTaP vaccines specifically, thigh injection in children 12-35 months reduces medically attended local reactions by 47% compared to arm injection (RR: 1.88,95% CI: 1.34-2.65) 9. However, this advantage diminishes in older children, making the deltoid appropriate once adequate muscle mass develops at age 3 years 1, 3, 9.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tdap Vaccination Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Tetanus Vaccination Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Deltoid Intramuscular Injection Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Injection sites utilized for DPT immunizations in infants.

Journal of community health nursing, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.